A tumor lysis-like syndrome during therapy of visceral leishmaniasis

dc.contributor.authorLiberopoulos, E.en
dc.contributor.authorAlexandridis, G.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T19:38:49Z
dc.date.available2015-11-24T19:38:49Z
dc.identifier.issn0091-7370-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24185
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAllopurinol/therapeutic useen
dc.subjectAmphotericin B/*adverse effectsen
dc.subjectAntimetabolites/therapeutic useen
dc.subjectAntiprotozoal Agents/*adverse effectsen
dc.subjectFemaleen
dc.subjectFluid Therapyen
dc.subjectHumansen
dc.subjectHydrogen-Ion Concentrationen
dc.subjectLeishmaniasis, Visceral/*drug therapyen
dc.subjectTumor Lysis Syndrome/drug therapy/*etiology/urineen
dc.subjectUrine/chemistryen
dc.titleA tumor lysis-like syndrome during therapy of visceral leishmaniasisen
heal.abstractReported herein for the first time in the literature is the case of a 41-yr-old woman who developed a tumor lysis-like syndrome, consisting of hyperkalemia, hyperphosphatemia, hyperuricemia, and acute renal insufficiency, soon after the initiation of chemotherapy for severe visceral leishmaniasis with liposomal amphotericin B. Allopurinol therapy, together with iv fluid administration and urine alkalization, resulted in full recovery of the metabolic abnormalities. Awareness of this condition can lead to prophylactic treatment as well as the early recognition and management of susceptible patients.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12458897-
heal.journalNameAnn Clin Lab Scien
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2002-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: